COVID-19: What are best practices for informed consent in CTIMPs? How can we help ensure these though Quality Management and Audit?

Webinar - Free Q&A Session

Description

Event Webinar
Type Virtual Event
Language English
Date(s) 07 Jun. 2021
Day(s) 17:00 - 18:00
Duration 1 hour

Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.

Programme

17:00 Opening of the Webinar Hugh Davies, National Research Ethics Service
The ethical requirements for consent processes: what RECs look for
Heather Sampson, University of Toronto
Hugh Davies, National Research Ethics Service
Quality management and consent: what QA is looking for
Seif Eddine Amara Madi, GSK
Open discussion and comment: “Good consent practice”Open discussion and comment: “Good consent practice”
Audit/Inspection and consent : standards, what we do now, what might be critical findings when auditing consent?
Belinda Pearce, BP Quality Solution
Panel and audience discussion : “Matching these up – how can QM and audit help?
Beat Widler, WS QMS
Cathy Dove, Dove Quality Solutions
Louise Mawer, Mirabilitas
Mark Poulton, Poulton Quality Solutions
18:00 End of the Webinar